tetano
Editor, Senior Moderator
J Infect Dis
. 2020 Jun 4;jiaa289.
doi: 10.1093/infdis/jiaa289. Online ahead of print.
Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-18 Season
Rebecca L Ursin[SUP] 1 [/SUP], Hsuan Liu[SUP] 2 [/SUP], Harrison R Powell[SUP] 2 [/SUP], Jason Westerbeck[SUP] 2 [/SUP], Kathryn Shaw-Saliba[SUP] 3 [/SUP], Kristyn E Sylvia[SUP] 2 [/SUP], Katherine J Fenstermacher[SUP] 3 [/SUP], Tom Mehoke[SUP] 4 [/SUP], Peter Thielen[SUP] 4 [/SUP], Richard E Rothman[SUP] 3 [/SUP], Andrew Pekosz[SUP] 2 [/SUP], Sabra L Klein[SUP] 1 2 [/SUP]
Affiliations
Abstract
Background: An antigenic mismatch between the vaccine and circulating H3N2 strains was hypothesized to contribute to the severity of the 2017-18 season in North America.
Methods: Serum and nasal washes were collected from influenza positive and negative patients during the 2017-18 season to determine neutralizing antibody (nAb) titers and for influenza virus sequencing, respectively.
Results: The circulating and vaccine H3N2 virus strains were different clades, with the vaccine strain being clade 3C.2a and the circulating viruses being 3C.2a2 or 3C.3a. At enrollment, both the H3N2 negative and positive patients had greater nAb titers to the egg-adapted vaccine virus compared to the cell-grown vaccine but the H3N2 negative population had significantly greater titers to the circulating 3C.2a2. Among H3N2 positive patients, vaccination, younger age, and female sex were associated with greater nAb responses to the egg-adapted vaccine H3N2 virus, but not to the cell-grown vaccine or circulating viruses.
Conclusions: For the 2017-18 circulating viruses, mutations introduced by egg-adaptation decreased vaccine efficacy. No increased protection was afforded by vaccination, younger age, or female sex against 2017-18 circulating H3N2 viruses.
Keywords: circulating influenza strain; egg-adaptation; human surveillance; neutralizing antibody; seasonal influenza vaccine; sex differences.
. 2020 Jun 4;jiaa289.
doi: 10.1093/infdis/jiaa289. Online ahead of print.
Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-18 Season
Rebecca L Ursin[SUP] 1 [/SUP], Hsuan Liu[SUP] 2 [/SUP], Harrison R Powell[SUP] 2 [/SUP], Jason Westerbeck[SUP] 2 [/SUP], Kathryn Shaw-Saliba[SUP] 3 [/SUP], Kristyn E Sylvia[SUP] 2 [/SUP], Katherine J Fenstermacher[SUP] 3 [/SUP], Tom Mehoke[SUP] 4 [/SUP], Peter Thielen[SUP] 4 [/SUP], Richard E Rothman[SUP] 3 [/SUP], Andrew Pekosz[SUP] 2 [/SUP], Sabra L Klein[SUP] 1 2 [/SUP]
Affiliations
- PMID: 32496543
- DOI: 10.1093/infdis/jiaa289
Abstract
Background: An antigenic mismatch between the vaccine and circulating H3N2 strains was hypothesized to contribute to the severity of the 2017-18 season in North America.
Methods: Serum and nasal washes were collected from influenza positive and negative patients during the 2017-18 season to determine neutralizing antibody (nAb) titers and for influenza virus sequencing, respectively.
Results: The circulating and vaccine H3N2 virus strains were different clades, with the vaccine strain being clade 3C.2a and the circulating viruses being 3C.2a2 or 3C.3a. At enrollment, both the H3N2 negative and positive patients had greater nAb titers to the egg-adapted vaccine virus compared to the cell-grown vaccine but the H3N2 negative population had significantly greater titers to the circulating 3C.2a2. Among H3N2 positive patients, vaccination, younger age, and female sex were associated with greater nAb responses to the egg-adapted vaccine H3N2 virus, but not to the cell-grown vaccine or circulating viruses.
Conclusions: For the 2017-18 circulating viruses, mutations introduced by egg-adaptation decreased vaccine efficacy. No increased protection was afforded by vaccination, younger age, or female sex against 2017-18 circulating H3N2 viruses.
Keywords: circulating influenza strain; egg-adaptation; human surveillance; neutralizing antibody; seasonal influenza vaccine; sex differences.